Log in
Enquire now
‌

US Patent 6951725 In vitro protein interaction detection systems

Patent 6951725 was granted and assigned to COMPOUND THERAPEUTICS, INC. on October, 2005 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Patent abstractTimelineTable: Further ResourcesReferences
Is a
Patent
Patent
1

Patent attributes

Current Assignee
‌
COMPOUND THERAPEUTICS, INC.
1
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
69517251
Patent Inventor Names
Markus Kurz1
Peter Lohse1
Date of Patent
October 4, 2005
1
Patent Application Number
101768261
Date Filed
June 20, 2002
1
Patent Citations Received
‌
US Patent 11926817 Microfluidic apparatus and methods of use thereof
2
Patent Primary Examiner
‌
Terry McKelvey
1
Patent abstract

Disclosed herein are in vitro assays for the identification of interactions between proteins or other molecules, the identification of transcriptional activator proteins, and the detection of compounds that inhibit protein/protein or protein/compound interactions. Also disclosed herein are in vitro assays for the selection of interacting proteins and transcriptional activator proteins out of libraries.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 6951725 In vitro protein interaction detection systems

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.